β1-adrenoceptor stimulation promotes LPS-induced cardiomyocyte apoptosis through activating PKA and enhancing CaMKII and IκBα phosphorylation

Abstract

IntroductionCaspase activation and cardiomyocyte apoptosis have been implicated in lipopolysaccharide (LPS)-induced cardiac contractile dysfunction. We have recently demonstrated that β1-adrenoceptor (AR) activation by endogenous norepinephrine contributes to cardiomyocyte apoptosis in endotoxemic mice. Here, we further investigated the molecular mechanisms for the enhancing effect of β1-AR activation on LPS-induced cardiomyocyte apoptosis.MethodsThe adult mouse ventricular myocytes were exposed to LPS, dobutamine, protein kinase A (PKA) inhibitor or/and nifedipine, an L-type Ca2+ channel blocker. Male BALB/c mice were treated with LPS or/ and β1-AR antagonist, atenolol. Cardiomyocyte apoptosis was determined by terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling (TUNEL) assay and apoptosis-associated molecules were detected.ResultsLPS induced apoptosis in adult mouse ventricular myocytes, dobutamine (DOB), a β1-AR agonist, promoted apoptosis, caspase-8, 9 and 3 activation and increased cytosolic Ca2+ concentration in LPS-challenged cardiomyocytes. DOB also up-regulated TNF-α expression, decreased Bcl-2 levels, promoted Bax translocation to mitochondria, mitochondrial membrane potential loss and cytochrome c release as well as IκBα, p38 MAPK, JNK and Ca2+/calmodulin-dependent protein kinase II (CaMKII) phosphorylation in LPS-treated cardiomyocytes. PKA inhibitor abolished the effects of DOB on caspase-9 activation, Bcl-2 levels as well as JNK and p38 MAPK phosphorylation, but not on IκBα phosphorylation, TNF-α expression and caspase-8 activation in LPS-stimulated cardiomyocytes. Pretreatment with nifedipine not only significantly blocked the enhancing effects of DOB on LPS-induced elevation in cytosolic Ca2+ concentration and CaMKII phosphorylation in cardiomyocytes, but also partly reversed the effects of DOB on caspase-9 and caspase-3/7 activities in LPS-treated cardiomyocytes. Furthermore, atenolol suppressed TNF-α expression, JNK, p38 MAPK and CaMKII phosphorylation, increased Bcl-2 expression, and inhibited cytochrome c release and cardiomyocyte apoptosis in the myocardium of endotoxemic mice.Conclusionsβ1-AR activation promotes LPS-induced apoptosis through activating PKA, increasing CaMKII phosphorylation as well as enhancing IκBα phosphorylation and TNF-α expression in cardiomyocytes.

Adipose derived mesenchymal stem cells alleviated osteoarthritis and chondrocyte apoptosis through autophagy inducing

“…A recent study reported that activated CAMKII inhibits autophagy through attenuating autophagosome formation. Also, overexpression of active CAMKII leads to cardiomyocyte apoptosis . However, whether this kinase has similar impact on OA chondrocytes have not been investigated.…”

“…Also, overexpression of active CAMKII leads to cardiomyocyte apoptosis. 59 However, whether this kinase has similar impact on OA chondrocytes have not been investigated. Our results showed that IL-1β stimulation upregulated the phosphorylation level of CAMKII accompanied by the decrease of autophagy marker LC3-II.…”

Prevalence and Prognostic Association of Circulating Troponin in the Acute Respiratory Distress Syndrome

“…Propranolol in severely burned children reduced heart rate and improved catabolism (29). In animal models, β-agonism was associated with increased lipopolysaccharide-induced myocyte necrosis (30) and β-blockade improved cardiac function (28), but the clinical implications of these experimental findings are unclear. Treatments targeted at alleviating right ventricular afterload and reducing right ventricular strain in ARDS are also appealing (27).…”

Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases

“…Compounds 56 , 57 , and the non-selective beta adrenergic receptor agonist isoproterenol ( 58 ) 314 increase PGC-1α in brown adipose of naïve mice and in models of obesity in a cAMP- and p62-dependent manner. 315 Interestingly, in models of cardiac dysfunction, beta-1 adrenergic receptor stimulation by dobutamine ( 59 ) 316 increases cell death and inflammation, 317 but its blockade by the beta-1 selective antagonist metoprolol ( 60 ) 318 enhances PGC-1α activation and improves cardiac metabolism and function. 319–320 Our laboratory has studied beta-2 adrenergic receptor selective agonists in renal MB.…”